This evidence gap reinforces the recommendation to discontinue GLP-1 therapy during the breastfeeding period
Details regarding the candidate were sparse in Mercks news release on Wednesday, with the pharma only revealing that HS-10535 is still in preclinical development
As research into metabolic health advances, GLP-1 agonists have emerged as a promising treatment for these conditions, extending their therapeutic benefits beyond diabetes and obesity management
How can parents choose a reliable clinic for stem cell therapy
In most cases, yesappealing almost always makes sense
Could GLP-1 drugs, the ones everyone knows from diabetes and weight loss, help people with pulmonary hypertension, a serious and often deadly condition of the heart and lungs